Greg Rodetis; Senior Vice President, Treasurer and Head of Investor Relations; Becton Dickinson and Co Thomas Polen; Chairman of the Board, President, Chief Executive Officer; Becton Dickinson and Co ...

The board of directors of Franklin Lakes-based, global medical technology company BD, has unanimously authorized BD management ...

Affiliated Engineers, Burns & McDonnell, Vanderweil Engineers, Tetra Tech High Performance Buildings Group, WSP, and Salas ...

HDR, Flad Architects, Gensler, HOK, DGA, and Payette top Building Design+Construction's ranking of the nation's largest ...

Becton Dickinson said it would focus on medtech and prioritize research, acquisitions and high-growth markets.

Becton, Dickinson and Company BDX, popularly known as BD, delivered adjusted earnings per share (EPS) of $3.43 in the first ...

Earnings Per Share (EPS) of $3.43, beating the estimated $3 and showing significant growth from the previous year’s $2.68. Revenue reached approximately $5.17 billion, surpassing the estimated $5.10 ...

In this trove of genetic information, the researchers identified 298 stretches of the genome containing gene variants that ...

At the request of BD, today's call is being recorded and will be available for replay on BD's Investor Relations website, investors.bd.com or by phone at 1-800-839-2486 for domestic calls and area ...

Becton Dickinson plans to spin off its Biosciences and Diagnostic Solutions unit, targeting a fiscal 2026 completion, while updating FY25 revenue guidance.

Becton Dickinson beat expectations for first-quarter results and said its board has authorized a plan to separate its biosciences and diagnostic solutions unit on Wednesday, as the medical device ...

BD (NYSE: BDX) announced that its board unanimously authorized management to pursue the separation of its Life Sciences business.